Affordable SARS-CoV-2 protein vaccines for the pandemic endgame

NPJ Vaccines. 2022 Aug 2;7(1):89. doi: 10.1038/s41541-022-00507-8.

James A Triccas^{1

2}, Joeri Kint³, Florian M Wurm^{3

4}

¹ School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia. jamie.triccas@sydney.edu.au.
² Sydney Institute for Infectious Diseases and the Charles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia. jamie.triccas@sydney.edu.au.
³ ExcellGene SA, 1870, Monthey, Switzerland.
⁴ Faculty of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.

No abstract available